Dr. Cohen Discusses Surgery in Early-Stage Ovarian Cancer

Joshua G. Cohen, MD
Published: Tuesday, Jun 12, 2018



Joshua G. Cohen, MD, assistant professor, Division of Gynecologic Oncology, University of California, Los Angeles, discusses surgery in patients with early-stage ovarian cancer.

There are varying subtypes of ovarian cancer, both histologically and molecularly, that imply differing courses of treatment, says Cohen. Many women with early-stage ovarian cancer do not need to undergo chemotherapy. These women have had their lymph nodes tested, and have undergone surgical biopsies to make sure that the cancer has not spread, explains Cohen.

Based on that, physicians can focus on fertility management, as many patients with early-stage ovarian cancer are younger. It gives these patients a unique opportunity to maintain their hormonal function, as well as possibly have children in the future.

There has been some controversy surrounding the idea of minimally-invasive surgery for early-stage ovarian cancer, Cohen says. Additionally, there is a new staging system, which some believe may impact how patients with ovarian cancer are managed.


Joshua G. Cohen, MD, assistant professor, Division of Gynecologic Oncology, University of California, Los Angeles, discusses surgery in patients with early-stage ovarian cancer.

There are varying subtypes of ovarian cancer, both histologically and molecularly, that imply differing courses of treatment, says Cohen. Many women with early-stage ovarian cancer do not need to undergo chemotherapy. These women have had their lymph nodes tested, and have undergone surgical biopsies to make sure that the cancer has not spread, explains Cohen.

Based on that, physicians can focus on fertility management, as many patients with early-stage ovarian cancer are younger. It gives these patients a unique opportunity to maintain their hormonal function, as well as possibly have children in the future.

There has been some controversy surrounding the idea of minimally-invasive surgery for early-stage ovarian cancer, Cohen says. Additionally, there is a new staging system, which some believe may impact how patients with ovarian cancer are managed.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Best Practice™: Expert Perspectives to Incorporate Evidence on PARP Inhibitors into Practice and Optimize the Medical Management of Ovarian CancerOct 31, 20181.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x